In 2021, UTRF awarded Zachry a Maturation Grant to help develop and test the Tummy Time Trainer.
HSC Office
University of Tennessee Technology and Research on the Forefront of COVID-19 Fight
“AUTM’s recognition of Dr. Peter Tsai and Dr. Michael Whitt emphasizes the high-caliber research and technology coming out of the UT System…”, UTRF President Dr. Stacey Patterson.
UTRF Licensee Announces Positive Phase 2 Clinical Results of VERU-111 for COVID-19
UTRF licensee Veru, Inc. announced today significant potential of VERU-111 in treating COVID-19, both as a broad-spectrum antiviral and an anti-inflammatory agent, which may help prevent effects leading to Acute Respiratory Distress Syndrome. Statistically significant data from the Phase 2 clinical study results show an 81% relative reduction in death or respiratory failure at Day (read more)